Develops a novel Ca2+ biosensor, enhancing ratiometric fluorescence in cellular imaging, suggesting improved detection methods.
The objective of this work was to overcome some of the long-standing limitations of ratiometric fluorescent protein (FP)-based Ca 2+ biosensors, which typically rely on Förster resonance energy transfer (FRET) between two FPs and generally exhibit only relatively modest Ca 2+ -dependent changes in emission ratio. To develop biosensors with substantially greater ratiometric changes, we explored an alternative biosensor design strategy in which two independently optimized intensiometric single FP-based Ca 2+ biosensors were hybridized into a single protein construct such that they employed a shared calmodulin (CaM) and CaM-binding peptide (CBP). By hybridizing a direct-response red FP-based biosensor with an inverse-response green FP-based biosensor, we created SuiCa, a single-polypeptide Ca 2+ biosensor that exhibits exceptionally large red-to-green ratiometric fluorescence changes as purified protein (∼60-fold) and when expressed in immortalized cell cultures (∼80-fold) and primary neurons (∼37-fold). Relative to co-expression of two spectrally distinct FP-based Ca 2+ biosensors, SuiCa provides the advantages of a smaller gene size, a fixed fluorophore stoichiometry, and a ratiometric response that depends on Ca 2+ binding to a single, shared, CaM plus CBP domain. With these advantages, along with its bright fluorescence and large ratiometric change, SuiCa represents a new addition to the Ca 2+ imaging toolbox.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: